Updated October 10, 2016

Ping Wang, PhD, D(ABCC), will serve as Director of the Clinical Chemistry Section and Core Laboratory starting October 2016. Dr. Wang received her BS degree in Biological Sciences and Biotechnology from Tsinghua University, China, in 2000, followed by a PhD in Molecular and Cellular Pharmacology from the University of Wisconsin-Madison. She completed a fellowship in Clinical Chemistry from the University of California-San Francisco in 2007. The same year, she was appointed Director of Clinical Chemistry at Houston Methodist Hospital, where she was also an attending faculty member in the Molecular Diagnostics Laboratory. Dr. Wang was also a Member of the Houston Methodist Hospital Research Institute where she went from Assistant Member (2008) to Associate Member (2013), as well as an Associate Professor in the Institute for Academic Medicine at Houston Methodist.  Dr. Wang was Director of the ComACC accredited postdoctoral fellowship in Clinical Chemistry at Houston Methodist. Dr. Wang is board certified in Clinical Chemistry, Toxicological Chemistry and Molecular Diagnostics. She was founding director of the accredited fellowship program in Clinical Chemistry at Houston Methodist and will develop a program here at Penn. She was recently elected as President of American Board of Clinical Chemistry and Commissioner for the ComACC Accredited Programs in Clinical Chemistry.

Rashmi Tondon, MD, joins the Division of Anatomic Pathology and the Surgical Pathology Section as a Gastrointestinal/Liver Pathologist Specialist. Dr. Tondon completed her medical degree (MBBS) in Kanpur India in 1999. In 2004, she completed a residency in Anatomic and Clinical Pathology in Allahabad, India. Dr. Tondon relocated to the United States where she began her AP/CP residency at Wayne State University/Detroit Medical Center in 2010. As A PGY2, Dr. Tondon transferred to finish her AP/CP residency at the Hospital of the University of Pennsylvania, where she also completed a Fellowship in Surgical Pathology and an additional fellowship in Gastrointestinal/Liver Pathology. She is well known to the Divisions of Gastrointestinal Medicine, Hepatology, GI Surgery and Liver Transplant through her multidisciplinary conference support and research endeavors.

Anupma Nayak, MBBS, MD, will join the Surgical Pathology Section of the Anatomic Division in October. Dr. Nayak received her medical training at King George Medical College, Lucknow, India and the All India Institute of Medical Sciences, New Delhi, India. She completed an Anatomic and Clinical Pathology residency at Albert Einstein College of Medicine/Long Island Jewish Hospital in 2010 and completed a selective pathology fellowship in breast pathology at MD Anderson Cancer Center in 2011. In 2011, Dr. Nayak started her academic career as an Assistant Professor in Pathology at Mount Sinai Medical Center and Icahn School of Medicine where her clinical pathology service concentrated heavily on breast pathology with a secondary interest in genitourinary pathology. At Mount Sinai she was active in graduate and undergraduate medical education, including directing the Fellowship in Breast Pathology. She was recognized for her excellence in teaching at Mount Sinai Medical Center and has proven herself to be a collaborative researcher. She is the author of 17 peer-reviewed publications in journals such as Breast Cancer Research and Treatment, Histopathology, Modern Pathology and American Journal of Surgical Pathology.

John Wojcik, MD, PhD, joins the Department as an Instructor concentrating in bone and soft tissue pathology in the Surgical Pathology Section in the Anatomic Pathology Division. John received his BS degree from the University of Notre Dame in 2004, followed by his MD/PhD degree from the University of Chicago, Pritzker School of Medicine in 2012. During his MD/PhD training, John was the recipient of the Outstanding Performance Award in the Department of Biochemistry and Molecular Biology in 2011 and won the Leon O. Jacobson Basic Science Prize for the most Meritorious Basic Science Research performed by an MD/PhD student. His graduate work resulted in eight publications, including a first-author paper in Nature Structural and Molecular Biology. In 2012, Dr. Wojcik began residency training in Anatomic Pathology at Massachusetts General Hospital. In 2014, he relocated to Philadelphia and finished his training in Anatomic Pathology at the Hospital of the University of Pennsylvania. John recently completed a fellowship in Bone and Soft Tissue Pathology at UPHS. His current research interests involve clinical and basic science characterizations of human sarcoma. With colleagues in the Epigenetics Program within the Department of Biochemistry and Molecular Biology at the University of Pennsylvania, John has established novel protocols for the proteomic and epigenomic characterization of human tumors. He was the recent recipient of Abramson Cancer Center’s Paul Calabresi Career Development Award for Clinical Oncology K12, Clinical Oncology Research Cancer Center Development Program.

Daniel S. Herman, MD, PhD, in the Clinical Chemistry Section to oversee the Endocrinology Laboratory as well as be involved with General Chemistry performed in the Core Automation Laboratory.  Dr. Herman’s activities will also include Laboratory Medicine informatics to better enable precision Laboratory Medicine, working with corporate IT partners to develop better algorithms for disease-based testing, developing strategies for better test utilization, and working with the Lab Medicine quality group on other lab analytical issues.  Dr. Herman received his BS degree in Biology from the Massachusetts Institute of Technology in 2004, and MD and PhD (Genetics) from Harvard Medical School in 2013. He completed his residency in Clinical Pathology at the University of Washington in Seattle, where he also served as Chief Resident in Clinical Pathology. Dr. Herman is the recent recipient of the Academy of Clinical Laboratory Physicians & Scientists (ACLPS) young investigator award (2015), the Association for Pathology Informatics 2015 Travel Award, and is a member of a number of national/international societies including the American Society of Clinical Pathologists, Association for Molecular Pathology, ACLPS, Association for Pathology Informatics and American Association for Clinical Chemistry. Dr. Herman’s research focus is to develop analytic methods for precision cardiovascular disease diagnosis and prognosis, to enable precision myocardial infarction diagnosis by developing explicit kinetic models of cardiac troponin concentrations and using them to inform diagnostic decision-making, and develop viable goals for biomarker-informed cardiovascular disease risk prediction and identify a set of existing biomarkers that improve prediction. Dr. Herman will develop this program with strong collaborations with the Institute for Bioinformatics, and Cardiovascular Medicine. He is a recipient of the 2016 Thomas B. McCabe and Jeannette E. Laws McCabe Fund at the Perelman School of Medicine in support of junior faculty who initiate innovative biomedical and surgical research projects.

John M. Astle, MD, PhD, will serve as a Clinical-Lecturer in the Division of Hematopathology. Dr. Astle received his BA with honors from the University of Utah, MD and PhD degrees from the University of Texas Southwestern Medical Center at Dallas, and completed Anatomic Pathology residency and Hematopathology fellowship training at Yale University. His research experience is diverse, ranging from the study of basic Drosophila development to developing proteomic tools to monitor and manipulate the immune system. Dr. Astle’s academic interests include the implementation of high-throughput technologies within diagnostic pathology, and in developing a structured informational resource that will help prevent the next generation of pathologists from “drowning in the sea of information” flooding the hematopathology field, and facilitate the efficient utilization of pathology "big data" for precision diagnosis.

Gabriel Caponetti, MD, will serve as an Assistant Professor in the Division of Hematopathology.  Dr. Caponetti received his MD degree from the University of Buenos Aires in 2003. He completed his residency in Anatomic and Clinical Pathology at Tufts University / Baystate Medical Center in Springfield, MA in 2009. He also completed a hematopathology fellowship at the University of Nebraska Medical Center, Omaha, NE in 2011 and a fellowship in molecular genetic pathology at University of Iowa Hospitals and Clinics in Iowa City, IA in 2012. From 2012 to June 2016, Dr. Caponetti worked as a hematopathologist at Creighton University Medical Center where he was the director of the hematology and flow cytometry laboratories. Dr. Caponetti’s research focus is in lymphoma, and he will soon begin to participate in a project that aims at characterizing the expression of PD-1, PD-L1, and other markers in double hit lymphomas.

Jason Rosenbaum, MD, will serve as Assistant Professor of Pathology and Laboratory Medicine and as an attending in the Division of Precision and Computational Diagnostics covering clinical service in the Center for Personalized Diagnostics and in Molecular Pathology. He will be actively involved in teaching and refining the curriculum for trainees in Next Generation Sequencing and process improvement in workflow and assay development in personalized diagnostics. Dr. Rosenbaum earned his MD from Northwestern University Feinberg School of Medicine and underwent residency training at University of Wisconsin Hospital and Clinics. He subsequently pursued subspecialty Molecular Genetic Pathology Fellowship training at Washington University, Barnes Hospital. In this fellowship position, he has acquired training and expertise in fundamental molecular diagnostics encompassing polymerase chain reaction based techniques, classical and molecular cytogenetics and next generation sequencing genomics in which he interprets sequencing data in a clinical molecular diagnostics laboratory setting. He is a Diplomate of the American Board of Pathology in Combined Anatomic and Clinical Pathology and an active member and participant of the Association of Molecular Pathology and the US Canadian Academy of Pathology. His academic interests include the utilization of next generation sequencing techniques to detect recurrent structural alterations in cancers; particularly lung cancer and angiosarcoma. He has been recognized with awards reflecting his aptitude in the field of clinical pathology including the University of Wisconsin Hospital and Clinics Quality Improvement Award (2013) and finalist in the Educations Category of the American Society for Clinical Pathology Annual Meeting (2013) among others.

Dr. Benjamin Wilkins, MD, PhD, as Assistant Professor in the Division of Anatomic Pathology at CHOP. Dr. Wilkins obtained his MD and PhD at the University of Cincinnati College of Medicine where he studied the molecular basis of hypertrophic cardiomyopathy. He then completed an anatomic pathology residency at the Washington University School of Medicine, followed by a pediatric pathology fellowship at CHOP. His research interests are to study the genetic basis of cholandiopathies using zebrafish as a model, and for which he was awarded an NIH K08 grant. As an Assistant Professor, Dr. Wilkins will continue his work on pediatric liver disease and will serve as an attending physician in the CHOP Division of Anatomic Pathology, with a special interest in GI pathology.  As a fellow, Dr. Wilkins won both the Neustein Award for Research and the Lotte Strauss Prize from the Society for Pediatric Pathology.

Lea Surrey, MD, will join the faculty August 1, 2016 as an Assistant Professor in the Divisions of Anatomic Pathology and Genomic Diagnostics at CHOP. She obtained her MD at Penn, where she then completed a combined Anatomic and Clinical Pathology Residency. Dr. Surrey then completed a pediatric pathology fellowship at CHOP and a molecular genetics fellowship at Penn. With a particular interest in cancer and with training in both pediatric pathology and molecular genetics, she will provide an important link between the Divisions of Anatomic Pathology and Genomics Diagnostics, splitting her clinical service time between these two divisions. Dr. Surrey has distinguished herself as an outstanding young pathologist, winning awards from both the Penn Department of Pathology and Laboratory Medicine as well as the Society for Pediatric Pathology.

Jeanne McFalls, MD, received her MD from Jefferson Medical College and completed residency training and a Dermatopathology Fellowship at Thomas Jefferson University. Dr. McFalls will have duties in Breast Pathology and Dermatopathology at Pennsylvania Hospital. In both, she will be a member of the corresponding HUP/UPHS Subspecialty team.

Ihad Lamzabi, MD, Assistant Professor of Clinical Pathology and Laboratory Medicine with a special interest in cytopathology at Pennsylvania Hospital. Dr. Lamzabi completed an AP/CP Residency at Rush University Medical Center in Chicago, a Surgical Pathology fellowship at Loyola University in 2014-15, and a Cytopathology fellowship at HUP in June 2016.  She will have duties in Surgical Pathology (GYN Pathology Subspecialty), and Cytopathology. In both, she will be a member of the corresponding HUP/UPHS Subspecialty team.

Ming Zhang, MD, PhD, Assistant Professor of Clinical Pathology and Laboratory Medicine with a special interest in cytopathology at Pennsylvania Hospital. Dr. Zhang completed an AP/CP Residency at Temple, a Surgical Pathology fellowship at HUP in 2014-15, and a Cytopathology fellowship at Memorial Sloan-Kettering in June 2016.  He will have duties in Surgical Pathology (ENT Pathology Subspecialty), and Cytopathology. In both, he will be a member of the corresponding HUP/UPHS Subspecialty team.

Yuanquan Song, PhD, Assistant Professor of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia.